$GRAL

GRAIL, Inc.

Nasdaq · Healthcare · Services-Medical Laboratories · Sunnyvale, CA

GRAL chart

What traders are saying about $GRAL

Latest posts

GRAIL, Inc. news

GRAIL, Inc. key financials

USD2025202420232022
Revenue$147.2M$125.6M$93.1M$55.5M
Net income-$408.4M-$2.03B-$1.47B-$5.40B
Diluted EPS$-11.11$-63.54$-47.21$-173.89
Total assets (year end)$2.92B$2.98B$3.91B–
Cash and equivalents (year end)$249.7M$214.2M$97.3M$241.6M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About GRAIL, Inc.

Ticker
GRAL (Nasdaq)
Industry
Services-Medical Laboratories
Headquarters
Sunnyvale, CA
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
1699031
Former names
GRAIL, LLC

Frequently asked questions

What exchange is GRAIL, Inc. listed on?

GRAIL, Inc. trades on the Nasdaq under the ticker symbol GRAL.

What industry is GRAIL, Inc. in?

GRAIL, Inc. is classified by the SEC under "Services-Medical Laboratories", part of the Healthcare sector on StockTweeting.

Where is GRAIL, Inc. headquartered?

GRAIL, Inc.'s business address on file with the SEC is in Sunnyvale, CA.

When does GRAIL, Inc.'s fiscal year end?

GRAIL, Inc.'s fiscal year ends on December 31.

How much revenue did GRAIL, Inc. report?

GRAIL, Inc. reported $147.2M in revenue for calendar year 2025, according to its SEC filings.